VRX 650 (Methoxsalen 10 mg)
Pill imprint VRX 650 has been identified as Methoxsalen 10 mg.
Methoxsalen is used in the treatment of cutaneous t-cell lymphoma; psoriasis and belongs to the drug class psoralens. There is positive evidence of human fetal risk during pregnancy. Methoxsalen 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
Methoxsalen
- Imprint:
- VRX 650
- Strength:
- 10 mg
- Color:
- Green
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Psoralens
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Oceanside Pharmaceuticals
More about methoxsalen
Consumer resources
- Methoxsalen hard-gelatin capsules
- Methoxsalen soft-gelatin capsules
- Methoxsalen
- Methoxsalen (Advanced Reading)
- Methoxsalen Injection (Advanced Reading)
- Other brands: Oxsoralen-Ultra, Uvadex, 8-MOP
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
